Dr. Ron Gasbarro
Rx-Press
East Lake Road
New Milford, PA 18834
(570) 465-2838
eMail Ron here
The following list contains a selection of published manuscripts for which Rx-Press provided editorial assistance, that is, Rx-Press supplied structure, research, organization, writing, referencing, and other activities necessary to get the manuscript into publishable form.
Manuscript title and publication information
| Adler L, Gasbarro RD. Diagnosis and treatment issues in adult ADHD. Amer Psychiatry News. 2008;1 (special report):1-8. Link |
| Arnold W, Fullerton DS, Holder S, May CS. Viscosupplementation: managed care issues for osteoarthritis of the knee. J Manag Care Pharm. 2007;13(suppl):S3-19. Link |
| Arrieta AC, Bradley JS. Empiric use of cefepime in the treatment of serious urinary tract infections in children. Pediatr Infect Dis J. 2001;20:350-5. |
| Barrie AM III, Plevy SE. The interleukin-12 family of cytokines: Therapeutic targets for inflammatory disease mediation. Clin Applied Immunol Rev. 2005;e225-40. Link |
| Blumer JL, Reed MD, Knupp C. Review of the pharmacokinetics of cefepime in children. Pediatr Infect Dis J. 2001;20:337-42. |
| Bradley JS, Arrieta A. Empiric use of cefepime in the treatment of lower respiratory tract infections in children. Pediatr Infect Dis J. 2001;20:343-9. |
| Campos C. Narrowing the cultural divide in diabetes mellitus care: a focus on improving cultural competency to better serve Hispanic/Latino populations. Insulin. 2006;1:70-6. Link |
| Cannon CP. The endocannabinoid system: a new approach to control cardiovascular disease. Clin Cornerstone. 2005;7:17-26. |
| Cannon E. Aligning patient care and asthma treatment guidelines. Am J Manag Care. 2005;11(14 Suppl):S416-21. Link |
| Cohen C. First-line treatment in HIV: many paths to success. J Acquir Immune Defic Syndr. 2003;33:S29-38. |
| Cohen M, Diez JE, Levine GN, et al; ACC; AHA. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report – III. J Invasive Cardiol. 2007;19:525-38. Link |
| Comella CL, Jankovic J, Brin MF. Use of botulinum toxin type A in the treatment of cervical dystonia. Neurology. 2000;55(12 Suppl 5):S15-21. |
| Cooksley WG, Piratvisuth T, Lee SD, et al. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J Viral Hepat. 2003;10:298-305. |
| Dardick K. Educating travelers about malaria: dealing with resistance and patient noncompliance. Cleve Clin J Med. 2002; 69:469-79. Link |
| Davila GW. Transdermal oxybutynin: a new treatment for overactive bladder. Expert Opin Pharmacother. 2003;4:2315-24. |
| Dmochowski RR, Nitti V, Staskin D, Luber K, Appell R, Davila GW. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J Urol. 2005;23:263-70. |
| Dyke CM, Jennings LK, Maier G, Andreou C, Daly R, Tamberella MR 3rd. Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass. J Cardiovasc Pharmacol Ther. 2007;12:54-60. |
| Fivenson DP. The mechanisms of action of nicotinamide and zinc in inflammatory skin disease. Cutis. 2006;77(1 Suppl):5-10. |
| Gasbarro R. Negative pressure wound therapy: a clinical review. Wounds. 2007;19(suppl):1-8. Link |
| Hernandez JD, Wesseling K, Salusky IB. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Semin Dial. 2005;18:290-5. |
| Hillier SL. How birth control changes your vaginal ecosystem. Fem Patient. 2006;(suppl):13-16. |
| Jensen JT, Nelson AL, Costales AC. Subject and clinician experience with the levonorgestrel-releasing intrauterine system. Contraception. 2008;77:22-9. |
| Jones SE. Antiaromatase agents: evolving role in adjuvant therapy. Clin Breast Cancer. 2002;3:33–42. |
| Kirshner HS. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician. Int J Clin Pract. 2007;61:1739-48. Link |
| Krishnan SM, Stark JG. Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers. Curr Med Res Opin. 2008;24:33-40. |
| Lasseter KC, Dilzer SC, Vargas R, Waldman S, Noveck RJ. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study. Clin Pharmacokinet. 2004;43:121-9. |
| Malik P, Balaban DH, Thompson WO, Galt DJ. Randomized study comparing two regimens of oral sodium phosphates solution versus low-dose polyethylene glycol and bisacodyl. Dig Dis Sci. 2008; 10.1007/s10620-008-0420-x. Link |
| Messerli FH, Oparil S, Feng Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol. 2000;86:1182-7. |
| Moyle GJ. Protease inhibitor-sparing regimens: new evidence strengthens position. J Acquir Immune Defic Syndr. 2003;33:S17-25. |
| Murphy RL. Reviving protease inhibitors: new data and more options. J Acquir Immune Defic Syndr. 2003;33:S43-52. |
| Navarro RP. Asthma treatment guidelines: how do we measure up? Am J Manag Care. 2005;11(14 Suppl):S422-6. Link |
| Neutel JM. The importance of 24-h blood pressure control. Blood Press Monit. 2001;6:9-16. |
| Parker LM. Sequencing of hormonal therapy in postmenopausal women with metastatic breast cancer. Clin Ther. 2002;24 (Suppl C):C43-57. |
| Pi-Sunyer FX. The relation of adipose tissue to cardiometabolic risk. Clin Cornerstone. 2006;8(suppl 4):S14-23. |
| Powderly WG. Limitations of current HIV therapies: opportunities for improvement. J Acquir Immune Defic Syndr. 2003;33:S7-12. |
| Ratner PH, Lim JC, Georges GC. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group. J Allergy Clin Immunol. 2000;105(6 Pt 1):1101-7. |
| Saez-Llorens X, O'Ryan M. Cefepime in the empiric treatment of meningitis in children. Pediatr Infect Dis J. 2001;20:356-61. |
| Schiff ER, de Medina M, Kahn RS. New perspectives in the diagnosis of hepatitis C. Semin Liver Dis. 1999;19 (Suppl 1):3-15. |
| Sebba A. Tocilizumab: the first interleukin-6-receptor inhibitor. Am J Health Syst Pharm. 2008;65:1413-8. |
| Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, et al; for Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 2005;115:1030-8. Link |
| Stotland NL. Overcoming psychological barriers in insulin therapy. Insulin. 2006;1:38-45. Link |
| Tellier G, Niederman MS, Nusrat R, Patel M, Lavin B. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. J Antimicrob Chemother. 2004;54:515-23. Link |
| Vinik AI. The metabolic basis of atherogenic dyslipidemia. Clin Cornerstone. 2005;7:27-35 |
| Watts RL, Raiser CD, Stover NP, et al. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm Suppl. 2003;215-27. |
| Weir MR. The role of multiple drug therapy for controlling hypertension in African Americans. J Clin Hypertens (Greenwich). 2000;2:99-108. |
Many more manuscripts are in the pre-published stage and involve the following disease stages and/or agent classes:
|
Adult ADHD |
Osteoarthritis |
Sleep disorders |
Rheumatoid arthritis |
|
Colorectal cancer |
Stroke |
Contraception |
HIV & hepatitis |
|
Diabetes |
Psoriasis |
Schizophrenia |
Asthma |
